Trial
NCT03386214
Pevonedistat in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Washington University School of Medicine
Collaborators
Takeda
Condition
Myelofibroses
Intervention
Pevonedistat
Why stopped
Sponsor stopped development of pevonedistat
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-01-06